• helpdesk@Lucintel.com
  • |
  • +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Proteomics Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


The future of the global proteomics market looks promising with opportunities in the clinical diagnostic and drug discovery. The global proteomics market is expected to grow with a CAGR of 13%-15% from 2020 to 2025. The major drivers for this market are increasing prevalence of diseases such as cancer, diabetes, and other cardiovascular diseases and increasing awareness related to personalized medicines among people.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global proteomics market report, please download the report brochure.
 
proteomics market
 
In this market, reagents is the largest component of proteomics, whereas clinical diagnostics is the largest application. Growth in various segments of the proteomics market are given below:
 
proteomics market
 
The study includes trends and forecast for the global proteomics market by component, application, and region as follows:
 
By Component [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Instruments
  • Spectroscopy
  • Chromatography
  • Electrophoresis
  • Protein Microarrays
  • X-Ray Crystallography
  • Surface Plasma Resonance
  • Protein Fractionation 
  • Reagents
  • Immunoassay Reagents
  • Spectroscopy Reagents
  • Chromatography Reagents
  • Protein Microarray Reagents
  • X-Ray Crystallography Reagents
  • Electrophoresis Reagents
  • Protein Fractionation Reagents
  • Services and Software
  • Core Proteomics Services
  • Bioinformatics Software & Services
By Application [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Clinical Diagnostic
  • Drug Discovery
  • Others 
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
  • North America
  • United States
  • Canada 
  • Mexico
  • Europe
  • United Kingdom
  • Germany
  • France
  • Asia Pacific
  • China
  • India
  • Japan
  • The Rest of the World 
  • Brazil
 
Some of the proteomic companies profiled in this report include Thermo Fisher Scientific, Agilent Technologies, GE Healthcare, Bio-Rad Laboratories, Danaher, Luminex, Bruker, Merck, Waters, and PerkinElmer.
Lucintel forecasts that reagents will remain the largest segment over the forecast period due to increasing research in academic institutes along with high frequency of usage of kits, reagent, chemicals, and strips for the analysis of biological samples.
 
Within this market, clinical diagnostic will remain the largest segment by application over the forecast period due to increasing awareness regarding relevance of investigation and understanding patterns of protein expression for drug development and disease diagnostics. 
 
North America will remain the largest region over the forecast period due to presence of sophisticated healthcare infrastructure, a large base of target population, and availability of advanced research facilities. 
 
 
Features of the Global Proteomics Market
 
  • Market Size Estimates: Global proteomics market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
  • Segmentation Analysis: Global proteomics market size by various segments, such as component and application in terms of value.
  • Regional Analysis: Global proteomics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different component, application, and region for the global proteomics market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global proteomics market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
 
 
 
This report answers following key questions
 
Q.1 What are some of the most promising potential, high-growth opportunities for the global proteomics market by component (instruments (spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasma resonance, and protein fractionation), reagents (immunoassay reagents, spectroscopy reagents, chromatography reagents, protein microarray reagents, X-ray crystallography reagents, electrophoresis reagents, and protein fractionation reagents), and services and software (core proteomics services and bioinformatics software & services), application (clinical diagnostic, drug discovery, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global proteomics market?
Q.5 What are the business risks and threats to the global proteomics market?
Q.6 What are the emerging trends in this proteomics market and the reasons behind them?
Q.7 What are some changing demands of customers in this proteomics market?
Q.8 What are the new developments in this proteomics market? Which companies are leading these developments?
Q.9 Who are the major players in this proteomics market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this proteomics market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global proteomics market?

 
 

Table of Contents
 
1. Executive Summary
 
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
 
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Proteomics Market Trends and Forecast
3.3: Global Proteomics Market by Component
3.3.1: Instruments
3.3.1.1: Spectroscopy
3.3.1.2: Chromatography
3.3.1.3: Electrophoresis
3.3.1.4: Protein Microarrays
3.3.1.5: X-Ray Crystallography
3.3.1.6: Surface Plasma Resonance
3.3.1.7: Protein Fractionation
3.3.2: Reagents
3.3.2.1: Immunoassay Reagents
3.3.2.2: Spectroscopy Reagents
3.3.2.3: Chromatography Reagents
3.3.2.4: Protein Microarray Reagents
3.3.2.5: X-Ray Crystallography Reagents
3.3.2.6: Electrophoresis Reagents
3.3.2.7: Protein Fractionation Reagents
3.3.3: Services and Software
3.3.3.1: Core Proteomics Services
3.3.3.2: Bioinformatics Software & Services
3.4: Global Proteomics Market by Application
3.4.1: Clinical Diagnostic
3.4.2: Drug Discovery
3.4.3: Others
 
4. Market Trends and Forecast Analysis by Region
4.1: Global Proteomics Market by Region
4.2: North American Proteomics Market
4.2.1: Market by Component: Instruments (Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, Surface Plasma Resonance, and Protein Fractionation), Reagents (Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, and Protein Fractionation Reagents), and Services and Software (Core Proteomics Services and Bioinformatics Software & Services
4.2.2: Market by Application: Clinical Diagnostic, Drug Discovery, and Others
4.2.3: The United States Proteomics Market
4.2.4: The Canadian Proteomics Market
4.2.5: The Mexican Proteomics Market
4.3: European Proteomics Market
4.3.1: Market by Component: Instruments (Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, Surface Plasma Resonance, and Protein Fractionation), Reagents (Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, and Protein Fractionation Reagents), and Services and Software (Core Proteomics Services and Bioinformatics Software & Services
4.3.2: Market by Application: Clinical Diagnostic, Drug Discovery, and Others 
4.3.3: The Proteomics Market of United Kingdom
4.3.4: The German Proteomics Market
4.3.5: The French Proteomics Market
4.4: APAC Proteomics Market
4.4.1: Market by Component: Instruments (Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, Surface Plasma Resonance, and Protein Fractionation), Reagents (Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, and Protein Fractionation Reagents), and Services and Software (Core Proteomics Services and Bioinformatics Software & Services
4.4.2: Market by Application: Clinical Diagnostic, Drug Discovery, and Others 
4.4.3: The Chinese Proteomics Market
4.4.4: The Indian Proteomics Market
4.4.5: The Japanese Proteomics Market
4.5: ROW Proteomics Market
4.5.1: Market by Component: Instruments (Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, Surface Plasma Resonance, and Protein Fractionation), Reagents (Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, and Protein Fractionation Reagents), and Services and Software (Core Proteomics Services and Bioinformatics Software & Services
4.5.2: Market by Application: Clinical Diagnostic, Drug Discovery, and Others 
4.5.3: Brazilian Proteomics Market
 
5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
 
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
 
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Proteomics Market by Component
7.1.2: Growth Opportunities for the Global Proteomics Market by Application
7.1.3: Growth Opportunities for the Global Proteomics Market by Region
7.2: Emerging Trends in the Global Proteomics Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Proteomics Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Proteomics Market
7.3.4: Certification and Licensing
 
8. Company Profiles of Leading Players
8.1: Thermo Fisher Scientific, Inc. 
8.2: Agilent Technologies, Inc. 
8.3: GE Healthcare
8.4: Bio-Rad Laboratories, Inc.
8.5: Danaher Corporation
8.6: Luminex Corporation
8.7: Bruker Corporation
8.8: Merck KGaA
8.9: Waters Corporation
8.10: PerkinElmer, Inc.
 
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Proteomics Market: Trends, Forecast and Competitive Analysis Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Below is a brief summary of the primary interviews that were conducted by job function for this report.

 
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.